Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms

被引:62
作者
Riley, Brigit E. [1 ]
Gardai, Shyra J. [1 ]
Emig-Agius, Dorothea [2 ]
Bessarabova, Marina [2 ]
Ivliev, Alexander E. [2 ]
Schuele, Birgit [3 ]
Alexander, Jeff [1 ]
Wallace, William [1 ]
Halliday, Glenda M. [4 ,5 ]
Langston, J. William [3 ]
Braxton, Scott [2 ]
Yednock, Ted [1 ]
Shaler, Thomas [6 ]
Johnston, Jennifer A. [1 ]
机构
[1] Elan Pharmaceut, San Francisco, CA 94080 USA
[2] Thomson Reuters, Carlsbad, CA USA
[3] Parkinsons Inst, Sunnyvale, CA USA
[4] Neurosci Res Australia, Sydney, NSW, Australia
[5] Univ New S Wales, Sydney, NSW, Australia
[6] SRI Int, Menlo Pk, CA 94025 USA
基金
英国医学研究理事会;
关键词
HUMAN SUBSTANTIA-NIGRA; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTIONAL ANALYSIS; PROTEOME ANALYSIS; ALPHA-SYNUCLEIN; QUANTIFICATION; IDENTIFICATION; PATHOGENESIS; ANNOTATION;
D O I
10.1371/journal.pone.0102909
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Detailed analysis of disease-affected tissue provides insight into molecular mechanisms contributing to pathogenesis. Substantia nigra, striatum, and cortex are functionally connected with increasing degrees of alpha-synuclein pathology in Parkinson's disease. We undertook functional and causal pathway analysis of gene expression and proteomic alterations in these three regions, and the data revealed pathways that correlated with disease progression. In addition, microarray and RNAseq experiments revealed previously unidentified causal changes related to oligodendrocyte function and synaptic vesicle release, and these and other changes were reflected across all brain regions. Importantly, subsets of these changes were replicated in Parkinson's disease blood; suggesting peripheral tissue may provide important avenues for understanding and measuring disease status and progression. Proteomic assessment revealed alterations in mitochondria and vesicular transport proteins that preceded gene expression changes indicating defects in translation and/or protein turnover. Our combined approach of proteomics, RNAseq and microarray analyses provides a comprehensive view of the molecular changes that accompany functional loss and alpha-synuclein pathology in Parkinson's disease, and may be instrumental to understand, diagnose and follow Parkinson's disease progression.
引用
收藏
页数:14
相关论文
共 73 条
[1]   Global signatures of protein and mRNA expression levels [J].
Abreu, Raquel de Sousa ;
Penalva, Luiz O. ;
Marcotte, Edward M. ;
Vogel, Christine .
MOLECULAR BIOSYSTEMS, 2009, 5 (12) :1512-1526
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   Proteome analysis of human substantia nigra in Parkinson's disease [J].
Basso, M ;
Giraudo, S ;
Corpillo, D ;
Bergamasco, B ;
Lopiano, L ;
Fasano, M .
PROTEOMICS, 2004, 4 (12) :3943-3952
[4]   Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders [J].
Beach, Thomas G. ;
Adler, Charles H. ;
Sue, Lucia I. ;
Vedders, Linda ;
Lue, LihFen ;
White, Charles L., III ;
Akiyama, Haru ;
Caviness, John N. ;
Shill, Holly A. ;
Sabbagh, Marwan N. ;
Walker, Douglas G. .
ACTA NEUROPATHOLOGICA, 2010, 119 (06) :689-702
[5]   The Gene Ontology in 2010: extensions and refinements The Gene Ontology Consortium [J].
Berardini, Tanya Z. ;
Li, Donghui ;
Huala, Eva ;
Bridges, Susan ;
Burgess, Shane ;
McCarthy, Fiona ;
Carbon, Seth ;
Lewis, Suzanna E. ;
Mungall, Christopher J. ;
Abdulla, Amina ;
Wood, Valerie ;
Feltrin, Erika ;
Valle, Giorgio ;
Chisholm, Rex L. ;
Fey, Petra ;
Gaudet, Pascale ;
Kibbe, Warren ;
Basu, Siddhartha ;
Bushmanova, Yulia ;
Eilbeck, Karen ;
Siegele, Deborah A. ;
McIntosh, Brenley ;
Renfro, Daniel ;
Zweifel, Adrienne ;
Hu, James C. ;
Ashburner, Michael ;
Tweedie, Susan ;
Alam-Faruque, Yasmin ;
Apweiler, Rolf ;
Auchinchloss, Andrea ;
Bairoch, Amos ;
Barrell, Daniel ;
Binns, David ;
Blatter, Marie-Claude ;
Bougueleret, Lydie ;
Boutet, Emmanuel ;
Breuza, Lionel ;
Bridge, Alan ;
Browne, Paul ;
Chan, Wei Mun ;
Coudert, Elizabeth ;
Daugherty, Louise ;
Dimmer, Emily ;
Eberhardt, Ruth ;
Estreicher, Anne ;
Famiglietti, Livia ;
Ferro-Rojas, Serenella ;
Feuermann, Marc ;
Foulger, Rebecca ;
Gruaz-Gumowski, Nadine .
NUCLEIC ACIDS RESEARCH, 2010, 38 :D331-D335
[6]   Knowledge-based analysis of proteomics data [J].
Bessarabova, Marina ;
Ishkin, Alexander ;
JeBailey, Lellean ;
Nikolskaya, Tatiana ;
Nikolsky, Yuri .
BMC BIOINFORMATICS, 2012, 13
[7]   Peripheral markers of apoptosis in Parkinson's disease the effect of Dopaminergic drugs [J].
Blandini, F ;
Mangiagalli, A ;
Cosentino, M ;
Marino, M ;
Samuele, A ;
Rasini, E ;
Fancellu, R ;
Martignoni, E ;
Riboldazzi, G ;
Calandrella, D ;
Frigo, GM ;
Nappi, G .
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 :675-678
[8]   Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry [J].
Bondarenko, PV ;
Chelius, D ;
Shaler, TA .
ANALYTICAL CHEMISTRY, 2002, 74 (18) :4741-4749
[9]   Evaluating Gene Expression in C57BL/6J and DBA/2J Mouse Striatum Using RNA-Seq and Microarrays [J].
Bottomly, Daniel ;
Walter, Nicole A. R. ;
Hunter, Jessica Ezzell ;
Darakjian, Priscila ;
Kawane, Sunita ;
Buck, Kari J. ;
Searles, Robert P. ;
Mooney, Michael ;
McWeeney, Shannon K. ;
Hitzemann, Robert .
PLOS ONE, 2011, 6 (03)
[10]   Stages in the development of Parkinson's disease-related pathology [J].
Braak, H ;
Ghebremedhin, E ;
Rüb, U ;
Bratzke, H ;
Del Tredici, K .
CELL AND TISSUE RESEARCH, 2004, 318 (01) :121-134